VCAM1 and hepatocellular carcinoma: Furthermore, Feng et al. (90) found that Irbesartan – ARB – effectively attenuated VCAM-1-mediated HCC cells adhesion during lung metastasis through inhibition of Ang II/AT1R-activated P38/MAPK pathway which responsible for increased VCAM-1 expression during HCC metastasis (90).